• Lead the Technology Development Research group responsible for allogeneic immune cell therapy research, cell and gene therapy technology development, platform capability expansion, and genome editing capabilities.
• Define scientific strategy for technology projects and platform initiatives, including goals, milestones, decision criteria, risks, and resource needs aligned with portfolio priorities.
• Oversee execution of research plans led by project leaders, and scientists, ensuring timely delivery of high-quality data and recommendations for project and portfolio decisions.
• Provide senior-level technical leadership in iPSC biology, immune cell differentiation, cellular engineering, genome editing, viral and non-viral delivery, and molecular biology.
• Translate early-stage research outputs into development-ready data packages, including CMC-relevant elements such as process characterization, analytical strategy, potency and functional assays, comparability, and documentation.
• Propose, prioritize, and lead technology initiatives and enhancements to strengthen the cell therapy portfolio.
• Manage, mentor, and develop project leaders, scientists, and research staff, fostering scientific rigor, accountability, leadership capability, and cross-functional collaboration.
• Oversee resource planning, personnel prioritization, external partner engagement, and budget input for assigned projects and technology initiatives.
• Represent Technology Research in governance discussions, project reviews, scientific forums, and selected external engagements; communicate complex scientific and strategic topics clearly to senior stakeholders.
• Prepare, review, and endorse project documentation.
• Ensure research activities are conducted with high scientific quality, documentation discipline, safety awareness, and compliance with internal policies, external standards, and regulatory expectations.
• Perform other duties as assigned.